Deep-AVPpred

Deep-AVPpred identifies potential antiviral peptides (AVPs) in protein sequences to support discovery of candidate antiviral therapeutics.


Key Features:

  • Deep learning classifier: Employs deep learning to classify sequences for antiviral peptide activity.
  • Transfer learning: Applies transfer learning within its algorithmic framework to improve identification accuracy.
  • Input data: Operates on protein sequences and includes analysis of human interferons-α family proteins.
  • Predictive performance: Reports approximately 94% precision on validation and 93% precision on test datasets.
  • Candidate generation: Proposes peptide candidates suitable for chemical synthesis and experimental validation.

Scientific Applications:

  • AVP discovery: Enables identification of novel antiviral peptides from protein sequences.
  • Candidate prioritization: Prioritizes peptides for chemical synthesis and experimental antiviral testing.
  • Therapeutic development: Supports antiviral drug discovery efforts for human and veterinary medicine.
  • Interferon analysis: Facilitates analysis of human interferons-α family proteins to propose AVP candidates.

Methodology:

The method uses a deep learning classifier applied to protein sequences and incorporates transfer learning to improve AVP identification.

Topics

Collections

Details

Cost:
Free of charge
Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Added:
6/7/2022
Last Updated:
6/7/2022

Operations

Publications

Sharma R, Shrivastava S, Singh SK, Kumar A, Singh AK, Saxena S. Deep-AVPpred: Artificial Intelligence Driven Discovery of Peptide Drugs for Viral Infections. IEEE Journal of Biomedical and Health Informatics. 2022;26(10):5067-5074. doi:10.1109/jbhi.2021.3130825. PMID:34822333.